Ward Dean MD

Ward Dean MD Dr. Dean specializes in the prevention and treatment of chronic degenerative diseases. Treatments include:

I.V. EDTA Chelation Therapy
I.V. Ozone Therapy
I.V.

As a world-renowned expert in anti-aging and life extension science, Dr. Dean is recognized for his pioneering work with innovative nutritional and pharmacological protocols to delay aging and ameliorate age-related diseases. Dr. Dean’s medical practice focuses on the prevention and treatment of chronic degenerative diseases. Vitamin C Therapy (high dose)
I.V. Hydrogen Peroxide
Hormone Replacement

Therapy (HRT)

Dr. Dean served on the Board of Directors of the American Aging Association, the founding Board of Directors of the American Academy of Anti-Aging Medicine, and was Vice-President of the International College of Advanced Longevity Medicine.

☎️ Call us at (850)912-6981 to schedule your free consultation.
04/10/2026

☎️ Call us at (850)912-6981 to schedule your free consultation.

04/09/2026

🤍If you have cancer, our office can help.

Please call us at (850)912-6981.

CLICK to SCHEDULE→ https://www.warddeanmd.com/contact/Doctors and researchers are stunned after an experimental treatmen...
04/07/2026

CLICK to SCHEDULE→ https://www.warddeanmd.com/contact/

Doctors and researchers are stunned after an experimental treatment using an anti-parasitic medication —once meant to fight infections showed unexpected success against cancer.

A patient once diagnosed with terminal cancer saw remarkable tumor regression, leaving experts amazed. Early studies suggest the drug might disrupt cancer cell metabolism and activate the immune system to fight tumors more effectively.

This breakthrough hints at a powerful idea — that the next big cancer treatment might already exist in our medicine cabinets.

CLICK to SCHEDULE→ https://www.warddeanmd.com/contact/A 2024 study published in Cancers (MDPI) (PMCID: PMC10814748) inve...
04/07/2026

CLICK to SCHEDULE→ https://www.warddeanmd.com/contact/

A 2024 study published in Cancers (MDPI) (PMCID: PMC10814748) investigated methylene blue as a treatment for platinum-resistant ovarian cancer. Researchers implanted carboplatin-resistant human ovarian cancer cells (TOV112D) into mice and observed tumor growth. They found that methylene blue significantly reduced tumor progression in vivo, even showing greater tumor slowdown compared to carboplatin alone in this resistant model.

The study showed this happened because methylene blue acts as a metabolic therapy targeting mitochondria. It altered mitochondrial respiration, oxygen consumption, and membrane potential, disrupting the cancer cells’ energy production. This metabolic stress likely triggered apoptosis (cell death), specifically affecting cancer cells more than normal cells, highlighting mitochondria as a key vulnerability in resistant ovarian cancer.
PMCID: PMC10814748 PMID: 38254843

CLICK to SCHEDULE→ https://www.warddeanmd.com/contact/Light-Activated Dye Shows Promise In Targeting Breast Cancer Cells...
04/07/2026

CLICK to SCHEDULE→ https://www.warddeanmd.com/contact/

Light-Activated Dye Shows Promise In Targeting Breast Cancer Cells

Researchers exploring innovative cancer treatments have reported promising findings using a combination of methylene blue and red light therapy. In laboratory studies, scientists observed that this approach was able to selectively destroy many human breast cancer cells while leaving most healthy breast cells largely unharmed.

To arrange your deworming program, please call (850)912-6981. 🪱
03/11/2026

To arrange your deworming program, please call (850)912-6981. 🪱

Address

6708 Plantation Road Suite C
Pensacola, FL
32504

Opening Hours

Monday 9am - 3pm
Tuesday 9am - 3pm
Wednesday 9am - 3pm
Thursday 9am - 3pm

Telephone

+18509126981

Website

Alerts

Be the first to know and let us send you an email when Ward Dean MD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category